Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in J Neurol

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    November 2018
  1. DE SIMONE MS, Perri R, Fadda L, Caltagirone C, et al
    Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests.
    J Neurol. 2018 Nov 1. pii: 10.1007/s00415-018-9108.
    PubMed     Text format     Abstract available


  2. AHMED RM, Goldberg ZL, Kaizik C, Kiernan MC, et al
    Neural correlates of changes in sexual function in frontotemporal dementia: implications for reward and physiological functioning.
    J Neurol. 2018;265:2562-2572.
    PubMed     Text format     Abstract available


    August 2018
  3. ONG SS, Proia AD, Whitson HE, Farsiu S, et al
    Ocular amyloid imaging at the crossroad of Alzheimer's disease and age-related macular degeneration: implications for diagnosis and therapy.
    J Neurol. 2018 Aug 28. pii: 10.1007/s00415-018-9028.
    PubMed     Text format     Abstract available


  4. PICKRELL WO, Robertson NP
    New treatments in Alzheimer's disease.
    J Neurol. 2018 Aug 21. pii: 10.1007/s00415-018-9018.
    PubMed     Text format    


  5. CHANDRA A, Dervenoulas G, Politis M
    Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.
    J Neurol. 2018 Aug 17. pii: 10.1007/s00415-018-9016.
    PubMed     Text format     Abstract available


  6. BOUGEA A, Stefanis L, Paraskevas GP, Emmanouilidou E, et al
    Neuropsychiatric symptoms and alpha-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    J Neurol. 2018 Aug 6. pii: 10.1007/s00415-018-8992.
    PubMed     Text format     Abstract available


  7. WEI H, Zhu X, Li Y
    Application value of serum biomarkers for choosing memantine therapy for moderate AD.
    J Neurol. 2018;265:1844-1849.
    PubMed     Text format     Abstract available


    April 2018
  8. ROALF DR, Rupert P, Mechanic-Hamilton D, Brennan L, et al
    Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease.
    J Neurol. 2018 Apr 4. pii: 10.1007/s00415-018-8841.
    PubMed     Text format     Abstract available


    February 2018
  9. AVGERINOS KI, Kalaitzidis G, Malli A, Kalaitzoglou D, et al
    Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.
    J Neurol. 2018 Feb 1. pii: 10.1007/s00415-018-8768.
    PubMed     Text format     Abstract available


    December 2017
  10. EDWARDS M, Robertson NP
    Seizures in Alzheimer's disease: is there more beneath the surface?
    J Neurol. 2017 Dec 4. pii: 10.1007/s00415-017-8694.
    PubMed     Text format    


    September 2017
  11. DE SIMONE MS, Perri R, Fadda L, De Tollis M, et al
    Different deficit patterns on word lists and short stories predict conversion to Alzheimer's disease in patients with amnestic mild cognitive impairment.
    J Neurol. 2017 Sep 25. doi: 10.1007/s00415-017-8623.
    PubMed     Text format     Abstract available


  12. LIGUORI C, Chiaravalloti A, Nuccetelli M, Izzi F, et al
    Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.
    J Neurol. 2017 Sep 12. doi: 10.1007/s00415-017-8613.
    PubMed     Text format     Abstract available


  13. CECCHINI MA, Yassuda MS, Bahia VS, de Souza LC, et al
    Recalling feature bindings differentiates Alzheimer's disease from frontotemporal dementia.
    J Neurol. 2017 Sep 11. doi: 10.1007/s00415-017-8614.
    PubMed     Text format     Abstract available


    August 2017
  14. KARAVASILIS E, Parthimos TP, Papatriantafyllou JD, Papageorgiou SG, et al
    A specific pattern of gray matter atrophy in Alzheimer's disease with depression.
    J Neurol. 2017 Aug 30. doi: 10.1007/s00415-017-8603.
    PubMed     Text format     Abstract available


  15. CAI Z, Wan CQ, Liu Z
    Astrocyte and Alzheimer's disease.
    J Neurol. 2017 Aug 18. doi: 10.1007/s00415-017-8593.
    PubMed     Text format     Abstract available


  16. HRASTELJ J, Robertson N
    Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies.
    J Neurol. 2017 Aug 7. doi: 10.1007/s00415-017-8584.
    PubMed     Text format    


    January 2017
  17. MALIK GA, Robertson NP
    Treatments in Alzheimer's disease.
    J Neurol. 2017 Jan 24. doi: 10.1007/s00415-017-8395.
    PubMed     Text format    


    December 2016
  18. TYNKKYNEN J, Hernesniemi JA, Laatikainen T, Havulinna AS, et al
    High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.
    J Neurol. 2016 Dec 30. doi: 10.1007/s00415-016-8378.
    PubMed     Text format     Abstract available


  19. KIMURA A, Takemura M, Saito K, Yoshikura N, et al
    Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
    J Neurol. 2016 Dec 20. doi: 10.1007/s00415-016-8362.
    PubMed     Text format     Abstract available


    October 2016
  20. CASTRO P, Zaman S, Holland A
    Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments.
    J Neurol. 2016.
    PubMed     Text format     Abstract available


  21. BORRELLO L, Cupidi C, Lagana V, Anfossi M, et al
    Angela R.: a familial Alzheimer's disease case in the days of Auguste D.
    J Neurol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  22. MASCALCHI M, Bessi V, Ginestroni A, Toschi N, et al
    Low MT ratio in hippocampus of amnestic MCI patients who will progress to AD.
    J Neurol. 2016;263:1024-6.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: